ArticlePatient preference and adherence2020
Realizing the Potential of the Patient Perspective.
Article in Patient preference and adherence, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder.Harm reduction journal · 2024Article
- Opioid use and HIV treatment services experiences among male criminal justice-involved persons in South Africa: a qualitative study.Harm reduction journal · 2023Article
- Hematochezia caused by tandospirone in a patient with major depressive disorder and anxious distress: a case report.Frontiers in psychiatry · 2023Article
- Building from Patient Experiences to Deliver Patient-Focused Healthcare Systems in Collaboration with Patients: A Call to Action.Therapeutic innovation & regulatory science · 2022Article
- The value of anticancer drugs - a regulatory view.Nature reviews. Clinical oncology · 2022Review
- Acne caused by ziprasidone in a young patient with bipolar disorder: A case report.Frontiers in psychiatry · 2022Article
- First-episode olfactory hallucination in a patient with anxiety disorder: A case report.Frontiers in psychiatry · 2022Article
- Influence of Jamaican Cultural and Religious Beliefs on Adherence to Pharmacotherapy for Non-Communicable Diseases: A Pharmacovigilance Perspective.Frontiers in pharmacology · 2022Article
- A Visual Analysis of Patient-Reported Outcomes in Lung Cancer From 2013 to 2023.Cancer control : journal of the Moffitt Cancer CenterReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Assessing a patient's perspective on their treatment is part of an increasingly integrated approach to pharmacovigilance and treatment optimization. New tools and methods developed in partnership with patients can capture and quantify cognitive and behavioral aspects of the treatment experience. These treatment insights have the potential to shape the drug development process, as well as supplement patient-reported outcome data in a way that is meaningful to the patient. We highlight examples of tools developed to assess the impact of treatment on the aspects of disease that are of utmost concern to the patient in their daily life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.